An Open-Label, Study to Treat Patients With Renal Allograft and Polyoma BK Viruria
Status:
Terminated
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the clinical efficacy and safety of a combination of leflunomide and
orotic acid in kidney transplant patients with high levels of Polyoma BK viruria for the
purpose of preventing Polyoma BK viremia and Nephropathy that could lead to kidney transplant
loss from viral damage, acute rejection or both.